IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens.
about
Controlling tumor-derived and vascular endothelial cell growth: role of the 4Ff2 cell surface antigenInterleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors.4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin.Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication.Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.Antibodies against major histocompatibility complex class II antigens directly inhibit the growth of T cells infected with Theileria parva without affecting their state of activation.Modulation of the interleukin 2 receptor by maternal and cord blood serum.Expression of HLA-DR mRNA in T cells following activation is early and can precede DNA synthesis.Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma.Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines.Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations.The interleukin-2 receptor on cord blood and nulliparous mononuclear cells is downregulated by maternal and cord blood serum.
P2860
Q35746649-2C6C892D-FAC9-42E1-93E6-AE0567B8E395Q35996768-9CF736AA-3943-481C-A132-5231E2F0FB7DQ36210119-3751C83F-E8BD-4B4E-B50F-3B39B1C745A6Q36348033-EF739368-C653-452A-93A3-1C9CE49D6CF3Q36348526-FD756387-2E34-46B8-9D69-FE3191258AB9Q36362189-46840A2A-EA17-4CC0-ADA5-930D404B2B90Q41751681-AF7CCC47-F672-49F1-9343-14CB8318F28CQ41940464-4571D3BB-E1B5-4808-80CB-62787CF02DBBQ42152584-D2B03DDA-568E-4B19-9244-CD391C4D7C1DQ42840254-112E28E2-77B3-436D-8D89-FD60268B9871Q42936818-FBAEF504-E61A-4C7F-BDFE-5FF80FF382E1Q42936989-F981055F-9ABE-4C7F-A173-9E71DCF95289Q44485123-3E10C620-18D3-48B4-8FD4-C568E1D5077C
P2860
IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
IL-2-mediated T cell prolifera ...... terminants of HLA-DR antigens.
@en
IL-2-mediated T cell prolifera ...... terminants of HLA-DR antigens.
@nl
type
label
IL-2-mediated T cell prolifera ...... terminants of HLA-DR antigens.
@en
IL-2-mediated T cell prolifera ...... terminants of HLA-DR antigens.
@nl
prefLabel
IL-2-mediated T cell prolifera ...... terminants of HLA-DR antigens.
@en
IL-2-mediated T cell prolifera ...... terminants of HLA-DR antigens.
@nl
P2093
P2860
P356
P1476
IL-2-mediated T cell prolifera ...... terminants of HLA-DR antigens.
@en
P2093
Accolla RS
Cerottini JC
P2860
P304
P356
10.1084/JEM.155.2.599
P407
P577
1982-02-01T00:00:00Z